CoStar is in a pronounced, sustained downtrend that has only recently begun to stabilize. The stock is down 56.5% over the past year and 50.8% year-to-date, a catastrophic relative performance gap versus the S&P 500's +15.5% one-year and +11.9% YTD returns, producing relative strength readings of -72.1 and -62.7 respectively. At $32.31, the stock sits at just 12.0% of its 52-week range of $25.89 to $79.08 — a positioning that historically signals either deep-value capitulation or a falling knife, and the -69.8% max drawdown confirms the severity of the de-rating. The price is holding roughly 25% above the 52-week low but nearly 59% below the 52-week high, meaning the long-term trend remains decisively broken even as the floor appears to be forming.

Short-term momentum has turned constructive and is diverging sharply from the longer-term downtrend. The stock is up 6.4% over the past month and 8.5% over three months, outperforming SPY by 5.2 and 5.8 percentage points respectively over those windows — a notable reversal after six-month performance of -18.7% and relative strength of -26.1. This pattern of positive 1-month and 3-month returns against a deeply negative 1-year trend is characteristic of mean-reversion off an oversold base rather than a confirmed trend reversal; the October move from $27.60 on October 7 to $32.31 on October 16 (+17% in seven sessions) on elevated volume of roughly 5.8 million shares suggests buyers are stepping in aggressively. The divergence signals that near-term selling pressure has been exhausted, but confirmation requires the stock to hold above the recent breakout zone.

Key technical levels are well defined. Support rests at the 52-week low of $25.89, with a secondary shelf around $27.00-$27.60 where the stock based in late September and early October; a breakdown below $25.89 would signal a fresh leg lower and likely trigger momentum-driven selling. Resistance sits at the 52-week high of $79.08, though the more actionable near-term hurdle is the $33-$34 area where the August rally stalled — a breakout above that zone would confirm a higher-low/higher-high structure and validate the recovery thesis. With a beta of 0.796, the stock is roughly 20% less volatile than the market, which is unusual for a name in such a steep drawdown and implies the selloff has been driven by company-specific fundamentals rather than broad market beta; position sizing should account for the fact that idiosyncratic risk, not market risk, is the dominant exposure here.

Revenue is growing at a healthy clip but the trajectory shows signs of moderation. Q2 2026 revenue of $925 million grew 18.4% year-over-year versus $781.3 million in Q2 2025, continuing a multi-quarter expansion from $897 million in Q1 2026, $900 million in Q4 2025, and $833.6 million in Q3 2025. The commercial real estate segment contributed $337 million of the most recent quarter's total, while the sequential growth from Q1 to Q2 (+3.1%) and the year-over-year acceleration reflect the scaling residential marketplace alongside the core subscription base. The investment case hinges on whether this ~18% growth rate can be sustained while the company laps the heavy Homes.com marketing spend, since the consensus revenue estimate of $5.52 billion implies continued double-digit expansion.

Profitability is the weak link and the source of the stock's de-rating. Q2 2026 net income was just $55 million on $925 million of revenue, a 5.9% net margin, with operating income of $76 million (8.2% operating margin) after $395 million of selling and marketing expense and $107 million of R&D. Gross margin remains robust at 74.8% (gross profit of $692 million), consistent with the 73.9%-79.3% band over the prior four quarters, but the operating margin has swung violently — from -6.1% in Q3 2025 to +8.2% in Q2 2026 — and the trailing operating margin of -2.2% underscores how marketing investment has overwhelmed the high-margin SaaS core. The path to the consensus forward EPS of ~$3.50 requires substantial operating leverage, and the Q2 improvement from the Q1 net income of just $3 million is an early but fragile sign that the loss-to-profit inflection may be underway.

Balance sheet strength is the company's most reassuring fundamental attribute. Debt-to-equity is only 0.137, the current ratio is a healthy 2.84, and cash stood at $1.266 billion at the end of Q2 2026, providing ample liquidity to fund the residential build-out without external financing. However, free cash flow has been erratic: TTM FCF is $312 million, but quarterly FCF swung from -$150.6 million in Q4 2025 to +$98 million in Q1 2026 to just +$12 million in Q2 2026 as capital expenditures of $103 million consumed most of the $115 million in operating cash flow. ROE of 0.08% and ROA of 0.47% are near zero, reflecting the earnings trough, while the company repurchased $527 million of stock in Q1 2026 and $84 million in Q2 — a signal of management confidence but also a use of cash that competes with growth investment.